Clinical data has reported mTOR signalling as a mechanism that connects mitochondrial disease to gliosis [116], with both in vitro [117], and in vivo, studies [118] showing that gliosis can be induced by targeted disruptions to mTOR signalling. The gene discussed is MTOR; the disease is mitochondrial disease.